Arrowhead Research reported $432.39M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Anika Therapeutics ANIK:US $ 167.86M 2.53M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
IONIS PHARMACEUT IONS:US $ 2191.15M 61.98M
Ligand Pharmaceuticals LGND:US $ 243.78M 32.28M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Moderna Inc MRNA:US 13.56B 2.79B
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Novartis NOVN:VX 38.14B 906M
Opko Health OPK:US $ 494.75M 259.32M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Spectrum Pharmaceuticals SPPI:US $ 73.58M 19.6M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
Xencor XNCR:US $ 585.94M 79.97M
YTE INCY:US $ 3625.84M 337.75M